Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vaes (Horn, Netherlands), M. Spruit (Horn, Netherlands), H. Van Hees (Nijmegen, Netherlands), E. Koolen (Nijmegen, Netherlands), J. Antons (Nijmegen, Netherlands), M. De Man (Uden, Netherlands), R. Djamin (Breda, Netherlands), A. Van 'T Hul (Nijmegen, Netherlands). ’Can do, do do’ concept and all-cause mortality risk in patients with COPD. 160

Member's Comments

No comment yet.

Related content which might interest you: Will the population ²at risk for COPD² develop COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005 Ability of the reduced severity rule crb-65 to detect high risk of short-term mortality from pneumonia in elderly patients Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015 No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Identifying risk groups for any cause hospitalizations in COPD patients Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Deaths in risk classes I-III: a measure of quality of care in patients hospitalised with CAP? Source: Eur Respir J 2004; 23: 103-105 Year: 2004 COPD the unseen factor causing increased morbidity and mortality among IHD patients Source: Annual Congress 2009 - COPD case-finding and management in primary care Year: 2009 Complexity of the relationship between cardiovascular co-morbidity, multi-dimensional assessment and mortality in a primary care cohort with COPD Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Prevalence of comorbidity in patients with COPD and its effect on mortality Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003 Validation of bode index as a predictor of mortality in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005